EFNB2 Antibody

Size

100ul

Clone Number

Aliases

EFN B2 antibody; EFNB 2 antibody; Efnb2 antibody; EFNB2_HUMAN antibody; Eph related receptor tyrosine kinase ligand 5 antibody; EPH-related receptor tyrosine kinase ligand 5 antibody; ephrin B2 antibody; Ephrin-B2 antibody; EphrinB2 antibody; EPLG 5 antibody; EPLG5 antibody; Htk L antibody; HTK ligand antibody; HTK-L antibody; HTKL antibody; LERK 5 antibody; LERK-5 antibody; LERK5 antibody; Ligand of eph related kinase 5 antibody; MGC126226 antibody; MGC126227 antibody; MGC126228 antibody; OTTMUSP00000024973 antibody

Immunogen Species

Homo sapiens (Human)

UniProt ID

P52799

Immunogen

Recombinant Human Ephrin-B2 protein (28-229AA)

Raised in

Rabbit

Species Reactivity

Human

Tested Applications

ELISA, IHC; Recommended dilution: IHC:1:20-1:200

Background

Cell surface transmembrane ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Binds to receptor tyrosine kinase including EPHA4, EPHA3 and EPHB4. Together with EPHB4 plays a central role in heart morphogenesis and angiogenesis through regulation of cell adhesion and cell migration. EPHB4-mediated forward signaling controls cellular repulsion and segregation from EFNB2-expressing cells. May play a role in constraining the orientation of longitudinally projecting axons.

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Conjugate

Non-conjugated

Buffer

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Form

Liquid

Stroage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names

EFNB2

Research Areas

Neuroscience; Cancer; Cardiovascular